Drug Product
Company Overview
About
Acino International AG is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Germany
Founded:2016
Employees:900
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval WC1CPF
FDA · #APR-KGWO9851 · 2018-10-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-O2YS9G2D
Issued: 2020-12-02
Expires: 2025-06-27
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-SNQAUAT3
Issued: 2020-09-21
Expires: 2025-10-04
Loading CDMO intelligence...
Key facts about Acino International AG
- Acino International AG is headquartered in Germany.
- Acino International AG was founded in 2016.
- Acino International AG has 900 employees.
- Acino International AG's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Acino International AG
Directory pages this company appears in, each with the full list of matching manufacturers.